Effects of diabetic ketoacidosis, islet cell function, and age of onset on pancreas size, morphology, and exocrine function in children with type 1 diabetes: an abdominal MRI study DOI

Zheng Cai,

Shaoqing Chen,

M. Chen

et al.

Journal of Endocrinological Investigation, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Language: Английский

Endothelial Cell Dysfunction: Onset, Progression, and Consequences DOI Creative Commons
Hojjat Naderi‐Meshkin, Wiwit Ananda Wahyu Setyaningsih

Frontiers in Bioscience-Landmark, Journal Year: 2024, Volume and Issue: 29(6), P. 223 - 223

Published: June 20, 2024

Endothelial cell dysfunction is a complex process involving various causes, early and late events, subsequent consequences. This review provides an overview of each aspect outlines therapeutic interventions targeting these stages. Causes endothelial encompass spectrum risk factors including hypertension, diabetes, smoking, obesity, inflammation, oxidative stress, genetic predispositions. Early events such as activation, inflammatory response, dysregulated vasomotor tone precede like apoptosis, microvascular rarefaction. The consequences include remodelling, neovascularization, organ dysfunction, clinical manifestations, highlighting the diverse impacts across multiple systems. While depicted linearly, progression dynamic, influenced by underlying cause affected vascular bed. Understanding dynamics crucial for tailoring interventions, ranging from lifestyle modifications to targeted therapies, address causes effects effectively. Here we provide comprehensive understanding that essential developing strategies mitigate impact this dysregulation on health cardiovascular diseases progression.

Language: Английский

Citations

5

Expression and diagnostic value of lncRNA MALAT1 and NLRP3 in lower limb atherosclerosis in diabetes DOI Creative Commons
Juan Li,

Chun Wang,

Chen Shao

et al.

BMC Endocrine Disorders, Journal Year: 2024, Volume and Issue: 24(1)

Published: March 4, 2024

Abstract Objective This study aimed to examine the diagnostic predictive value of long non-coding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1(MALAT1) and NOD-like receptor protein 3(NLRP3) expression in patients with type 2 diabetes mellitus(T2DM) lower extremity atherosclerosis disease (LEAD). Methods A total 162 T2DM were divided into LEAD group (T2DM + group) alone group). The lncRNA MALAT1 NLRP3 levels measured peripheral blood, their correlation was examined. Least absolute shrinkage selection operator (LASSO) regression model used screen for best predictors LEAD, multivariate logistic establish a construct nomogram. effectiveness nomogram assessed using receiver operating characteristic (ROC) curve, area under curve (AUC), calibration decision analysis (DCA). Results significantly greater than those ( P <0.001), level positively correlated that r = 0.453, <0.001). results LASSO combined showed age, smoking, systolic blood pressure (SBP), NLRP3, influencing factors LEAD( <0.05). ROC comparison: discriminatory ability (AUC 0.898), 0.804), 0.794) other indicators, greatest. Calibration curve: consistent predicting occurrence (Cindex 0.898). Decision net benefit rates obtained from models clinical intervention decision-making individual within model. Conclusion increased while revealing between NLRP3. found as potential biomarker LEAD.

Language: Английский

Citations

4

Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients DOI Creative Commons

Xiao-Yun Zha,

Chang-Shun Wei,

Jiajia Dong

et al.

Diabetes Metabolic Syndrome and Obesity, Journal Year: 2025, Volume and Issue: Volume 18, P. 51 - 59

Published: Jan. 1, 2025

This study aims to analyze the impact of serum C-peptide levels in patients with newly diagnosed type 2 diabetes (T2DM) on 10-year risk atherosclerotic cardiovascular disease (ASCVD). A total 1923 T2DM were selected and categorized into four groups based interquartile range fasting (FCP) levels: Q1 group (FCP≤0.568 ng/mL), Q2 (0.568 < FCP≤0.751 Q3 (0.751 FCP≤0.980 Q4 (FCP > 0.980 ng/mL). Clinical data collected, China-PAR model was employed evaluate score ASCVD within 10 years. Additionally, correlation between FCP analyzed. As quartiles increased, exhibited a gradual increase. The ng/mL significantly higher than that other groups, noted differences related gender weight. Multiple linear regression analysis indicated that, even after adjusting for confounding factors such as gender, age, body mass index (BMI), glycosylated hemoglobin, remained positive predictor risk. High are identified factor years T2DM.

Language: Английский

Citations

0

Positive Islet Cell Cytoplasmic Antibody and Long‐Term Use of Lipid‐Lowering Agents Are Positively Correlated With Peripheral Atherosclerosis in Patients With Autoimmune Diabetes: A Cross‐Sectional Study DOI Creative Commons
Xinyue Chen, Jie Yu, Yiwen Liu

et al.

Journal of Diabetes Research, Journal Year: 2025, Volume and Issue: 2025(1)

Published: Jan. 1, 2025

Aims: This cross‐sectional study is aimed at determining whether systemic inflammation, diabetic autoantibodies, and islet β cell dysfunction play a role in the progression of macrovascular complications patients with autoimmune diabetes. Methods: 202 diabetes aged ≥ 35 years hospitalized Peking Union Medical College Hospital were enrolled this study. The divided into three groups based on severity peripheral atherosclerosis. Biomarkers function, other covariates validated to be associated collected. Correlations between atherosclerosis function examined using an ordinal logistic regression model. Results: Of patients, 39.1% male, median age 53 (43, 60) duration 96 (36, 216) months. 58 had no lesions arteries, 72 carotid or lower extremity rest both arteries. In multifactor test, positive cytoplasmic antibody (ICA) long‐term use lipid‐lowering agents independently after adjusting for duration. Conclusions: correlation ICA suggests inflammation early stage plays association need screening intervention dyslipidemia

Language: Английский

Citations

0

Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications DOI Creative Commons
Siqi Wang, Hongyu Yang, Jiaying Zheng

et al.

Theranostics, Journal Year: 2025, Volume and Issue: 15(8), P. 3551 - 3570

Published: Feb. 25, 2025

Diabetes mellitus (DM) is a chronic metabolic disorder that significantly affects various organ systems. The systemic effects of DM lead to numerous complications, with ocular manifestations being particular concern due their severity and impact on quality life. Hyperglycemia-induced damage often results in range lesions, including diabetic retinopathy (DR), keratopathy, cataracts, glaucoma. These conditions impose considerable physical discomfort patients place substantial economic burden healthcare advent nanotechnology has facilitated the development innovative therapeutic strategies for managing complications. This review highlights several common complications associated DM, focusing pathogenesis treatment strategies. Emphasis placed applications potential treating

Language: Английский

Citations

0

Fasting plasma C‐peptide correlates with body mass index, hsCRP, apolipoprotein B, and other atherogenic lipids in healthy individuals DOI Creative Commons
Per A Whiss, Evangelia Baldimtsi, Jeanette Wahlberg

et al.

Physiological Reports, Journal Year: 2025, Volume and Issue: 13(6)

Published: March 1, 2025

C-peptide has a complex role in human physiology, but its effects are not fully understood. Studies have shown protective impact against diabetic complications, also that levels associate with cardiovascular events. Among the many applications to assess risk, circulating lipids widely used, and one of strongest biomarkers is apolipoprotein B. The aim this investigation was study association markers metabolic, inflammatory, or alterations limited group healthy individuals. Body mass index (BMI), lipids, other plasma were studied 28 consecutive individuals within age 30-50 years. results showed significant positive correlations between BMI (r = 0.498; p 0.007); hsCRP 0.530; 0.004); triglycerides 0.005); cholesterol 0.507; 0.006), LDL-cholesterol 0.550; 0.002), LDL/HDL ratio 0.460; 0.014); apoB 0.622; < 0.001), apoB/apoA1 0.563; 0.002); non-HDL 0.566; 0.002). According values, 16 overweight (BMI >25.0 kg/m2). If excluded, did only correlate 0.636; 0.026). To conclude, normal atherogenic individuals, even at weight. These suggest can be an early additional risk marker.

Language: Английский

Citations

0

Effects of diabetic ketoacidosis, islet cell function, and age of onset on pancreas size, morphology, and exocrine function in children with type 1 diabetes: an abdominal MRI study DOI

Zheng Cai,

Shaoqing Chen,

M. Chen

et al.

Journal of Endocrinological Investigation, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Language: Английский

Citations

0